Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.

Current medical research and opinion - 1 Apr 2009

Yancey Steven W, Klotsman Michael, Ortega Hector G, Edwards Lisa D, Anderson Wayne H

Abstract excerpt

OBJECTIVE: There is conflicting clinical evidence describing the response to long-acting beta-agonist (LABA) bronchodilators for patients with Arg16Gly beta(2)-adrenergic receptor (ADRB2 ) genotype differences. Furthermore, the role of inhaled corticosteroids (ICS) in modulating Arg16Gly clinical responses is not well understood. The objective of this study was to investigate the effects of Arg16Gly polymorphism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Agonists
Share to Albuterol

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Androstadienes

Share to Arginine

Share to Bronchodilator Agents

Share to Glycine

Share to Receptors, Adrenergic, beta-2

Share to Respiratory Function Tests

Source

Identifiers

PMID: 19275519
DOI: 10.1185/03007990902805981

Genes

ADRB2
FEV

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.PMID 19275519Read ↗

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.Semantic proximity Read ↗

beta-Adrenergic receptor polymorphisms and response to salmeterol.Semantic proximity Read ↗

Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol.Semantic proximity Read ↗

Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.Semantic proximity Read ↗

ADRB2 Gly16Arg polymorphism, asthma control and lung function decline.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.Semantic proximity Read ↗

Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide.Semantic proximity Read ↗

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.Semantic proximity Read ↗

The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.Semantic proximity Read ↗

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.Semantic proximity Read ↗

beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.